| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.42 (Beat by $0.14) |
| EPS GAAP Actual | $0.42 (Beat by $0.14) |
| Revenue Actual | $0.725106B |
| Revenue Surprise | Beat by $725.106M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 2 |
| Dec 2028 | 1.29612 | 36.87 | 1.18241 | 1.39924 | 8 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.3 | -0.3 | 0.725106B | 63.35% | 725.11M |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 0.739259B | 45.62% | 739.26M |
| FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 0.329276B | -8.03% | 329.28M |
| FQ4 2024 (Dec 2024) | -0.1 | -0.1 | 0.332197B | -4.59% | 332.2M |
| FQ3 2024 (Sep 2024) | 0.0428 | 0.0428 | 0.265748B | 100% | 265.75M |
| FQ2 2024 (Jun 2024) | 0.29 | 0.29 | 0.401977B | 100% | 401.98M |
| FQ1 2024 (Mar 2024) | 0.28 | 0.28 | 0.355708B | 100% | 355.71M |
| FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 0.347435B | 100% | 347.44M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.64 | -- | 0.56169 | 0.70558 | 4 |
| FQ3 2028 (Sep 2028) | 0.69 | -- | 0.60557 | 0.7607 | 6 |
| FQ2 2028 (Jun 2028) | 0.67 | -- | 0.58802 | 0.73865 | 4 |
| FQ1 2028 (Mar 2028) | 0.54 | -- | 0.47392 | 0.59533 | 4 |
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 4 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 3 |
| FQ2 2027 (Jun 2027) | 0.53297 | -- | 0.46775 | 0.58758 | 3 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.06B | -- | 0.96B | 1.14B | 4 |
| FQ3 2028 (Sep 2028) | 1.17B | -- | 1.06B | 1.27B | 4 |
| FQ2 2028 (Jun 2028) | 1.16B | -- | 1.05B | 1.25B | 4 |
| FQ1 2028 (Mar 2028) | 0.96B | -- | 0.87B | 1.04B | 4 |
| FQ4 2027 (Oct 2027) | 0.87B | -- | 0.82B | 0.94B | 5 |
| FQ3 2027 (Jul 2027) | 0.76B | -- | 0.71B | 0.82B | 5 |
| FQ2 2027 (Jun 2027) | 0.97B | -- | 0.88B | 1.04B | 5 |
| FQ1 2027 (Mar 2027) | 0.65B | -- | 0.61B | 0.7B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.3 | -0.3 | 100% | |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 100% | |
| FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 100% | |
| FQ4 2024 (Dec 2024) | -0.1 | -0.1 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0428 | 0.0428 | 100% | |
| FQ2 2024 (Jun 2024) | 0.29 | 0.29 | 100% | |
| FQ1 2024 (Mar 2024) | 0.28 | 0.28 | 100% | |
| FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.73B | $725.11M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.74B | $739.26M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.33B | $329.28M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.33B | $332.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.27B | $265.75M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.4B | $401.98M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.36B | $355.71M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.35B | $347.44M | 100% |